HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 10 analysts with an average price target of $81.43. This is a potential upside of -$28.99 (-26.25%) from yesterday's end of day stock price of $110.42.

Halozyme Therapeutics's activity chart (see below) currently has 316 price targets and 242 ratings on display. The stock rating distribution of HALO is 3.45% SELL, 79.31% BUY and 17.24% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.08% with an average time for these price targets to be met of 235.09 days.

Highest price target for HALO is $115, Lowest price target is $56, average price target is $81.43.

Most recent stock forecast was given by JESSICA FYE from JPMORGAN. First documented stock forecast 29-Apr-2014.

Best performing analysts who are covering HALO - Halozyme Therapeutics:

Jason Butler Jim Birchenough Brendan Smith Mitchell Kapoor Sean Laaman Vikram Purohit

Currently out of the existing stock ratings of HALO, 1 are a SELL (3.45%), 23 are a BUY (79.31%), 5 are a HOLD (17.24%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Apr-2025

$78

$-32.42 (-29.36%)

$65

Buy Since 24-Jul-2023

$115

$4.58 (4.15%)

$115

1 months 10 days ago
(02-Sep-2026)

46/46 (100%)

$5.34 (4.87%)

176

Buy Since 29-Feb-2024

$105

$-5.42 (-4.91%)

$96

2 months 5 days ago
(07-Aug-2026)

12/12 (100%)

$1.88 (1.82%)

168

Buy Since 27-Nov-2018

$93

$-17.42 (-15.78%)

$92

2 months 5 days ago
(07-Aug-2026)

18/19 (94.74%)

$-10.12 (-9.81%)

366

Hold Since 13-Jan-2025

$95

$-15.42 (-13.96%)

$75

2 months 5 days ago
(07-Aug-2026)

10/11 (90.91%)

$-8.12 (-7.87%)

288

Show more analysts

Please expand the browser size to see the chart

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 235 days for the stock forecasts to be reached, with an average price target met ratio of 85.08%.

Which analyst most recently updated their price target on HALO (Halozyme Therapeutics)?

Jessica Fye

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Jessica Fye works at JPMORGAN and has 2 price targets and 2 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Vikram Purohit with the highest potential upside of $18.04

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with the lowest potential downside of -$97.42
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?